Hungary's National Health Insurance Fund is expected to record adeficit of 40-60 billion forint ($22.2-$33.4 million) this year, over 10 times the originally-budgeted 3.84 billion forint, reports MTI Econews.
Revenues are expected to be 25-30 billion forint less than the budgeted 669.18 billion forint, with expenses 20-25 billion up on the budgeted 673.02 billion forint.
With a deficit of 15.6 billion forint in first-quarter 1997, the Fund is likely to draw up a supplementary budget. Its 1996 drug subsidies were 2.39 billion forint up on the budgeted 81.85 billion forint.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze